Company · Healthtech & Bio

Aortyx

aortyx.com ↗ ·Barcelona ·Series A

Aortyx is a Barcelona-based medtech company developing a bioresorbable, biomimetic endovascular patch to treat aortic dissections, delivered via a proprietary dual-steerable catheter as a minimally invasive alternative to open surgery or stent grafts. Founded in 2018 as a spin-off from IQS School of Engineering and Hospital Clínic de Barcelona, it closed a €13.8M Series A in June 2025 to advance toward first-in-human trials.

Founded
2018
Founders
4
News
0
Rounds
2
Investors
6
SectorsMedical Devices, Vascular Surgery, Biomaterials Start-up MapHealthtech & Bio › Medical devices & surgical hardware

Profile updated 23 Jul 2026

Founders

Jordi Martorell
CEO & Co-Founder
Noemí Balà
CTO & Co-Founder
Salvador Borrós
CSO & Co-Founder
Vicenç Riambau
CMO & Co-Founder (Head of Vascular Surgery, Hospital Clínic de Barcelona)
—

Global models 5

Shockwave Medical
United States · www.shockwavemedical.com ↗
VC-backed catheter-delivered device company treating vascular disease (calcified plaque via intravascular lithotripsy), later acquired by J&J for $13.1B — same model of novel minimally invasive endovascular devices replacing surgery/stents.
$450MComparable
Ancora Heart
United States · www.ancoraheart.com ↗
VC-funded developer of catheter-delivered structural cardiovascular repair devices, similar to Aortyx's catheter-based approach to structural vascular repair.
$260MComparable
CathWorks
Israel / United States · cathworks.com ↗
VC-funded catheter-based vascular device/diagnostics company targeting minimally invasive alternatives to invasive vascular procedures.
$180MComparable
Silk Road Medical
United States · www.silkroadmed.com ↗
VC-backed developer of a catheter-delivered device (TCAR) for carotid artery disease, a close analogue to Aortyx's catheter-delivered aortic patch.
$150MComparable
TriVascular Technologies
United States · www.trivascular.com ↗
VC-funded maker of a minimally invasive aortic stent-graft system for aortic aneurysm repair, directly comparable to Aortyx's endovascular aortic device model.
$150MComparable

Investors 6

Centro para el Desarrollo Tecnológico y la Innovación
cdti.es
Investor Spain
Clave Capital
clave.capital
Investor Spain
EIC Fund
eic.ec.europa.eu/eic-fund_en
Investor Luxembourg
EIT Health
eithealth.eu ↗
Investor Germany
Nara Capital
www.nara.capital/en
Investor Spain
Ship2B Ventures
ship2bventures.com
Investor Spain

Funding rounds 2

Series A · €13.8M
Aortyx raised a €13.8M Series A co-led by Ship2B Ventures (through its BSocial Impact Fund, backed by Banco Sabadell, the EIF and AXIS) and …
2025-06-12
Seed · €650K
Aortyx, a spin-off of IQS School of Engineering and Hospital Clínic de Barcelona that is developing an endovascular device to treat aortic d…
2020-03-05

News & media

No coverage on record yet.
Start typing to search across everything.
↑↓ navigate↵ openesc close